home / stock / mor / mor news

MOR News and Press, MorphoSys AG From 11/22/23

Stock Information
Company Name: MorphoSys AG
Stock Symbol: MOR
Market: NASDAQ
Website: morphosys.com
Menu
MOR MOR Quote MOR Short MOR News MOR Articles MOR Message Board
Get MOR Alerts

News, Short Squeeze, Breakout and More Instantly...
MOR - Alterity Therapeutics, Edesa Biotech among healthcare movers

2023-11-22 10:00:14 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...
MOR - LogicMark, Morphosys AG among healthcare movers

2023-11-21 09:59:42 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...

MOR - SBSW, LGMK and MNOV among pre-market losers

2023-11-21 08:16:38 ET Losers: Morphosys AG ( MOR ) -24% . Sibanye Stillwater Limited ( SBSW ) -23% . reAlpha Tech Corp. ( AIRE ) -14% . Alzamend Neuro ( ALZN ) -16% . American Eagle Outfitters AEO -13% after Q3 earning release ....

MOR - Biggest stock movers today: Agilent Technologies, MorphySys and more

2023-11-21 04:52:38 ET Related stories Symbotic Inc. (SYM) Q4 2023 Earnings Call Transcript Agilent Technologies, Inc. (A) Q4 2023 Earnings Call Transcript MorphoSys: Buying Constellation Was A Desperate Measure For further details see: Biggest stock move...
MOR - Biggest stock movers today: Agilent Technologies, MorphoSys and more

2023-11-21 04:52:38 ET Related stories Symbotic Inc. (SYM) Q4 2023 Earnings Call Transcript Agilent Technologies, Inc. (A) Q4 2023 Earnings Call Transcript MorphoSys: Buying Constellation Was A Desperate Measure For further details see: Biggest stock move...

MOR - FYBR, MNMD and OM are among after hour movers

2023-11-20 17:34:17 ET Symbotic  ( SYM ) +20% . Veradigm  ( MDRX ) +6% . Tactile Systems Technology ( TCMD ) +6% . Farmer Brothers Company ( FARM ) +4% . Outset Medical ( OM ) +4% . MorphoSys  ( MOR ) -32% ...

MOR - MorphoSys reports positive Phase 3 results for myelofibrosis drug candidate

2023-11-20 17:12:31 ET More on MorphoSys MorphoSys: Buying Constellation Was A Desperate Measure MorphoSys: Still Positive Moving Into Pelabresib Data (Maintaining Buy Rating) MorphoSys AG 2023 Q3 - Results - Earnings Call Presentation I-Mab gains FDA breakth...
MOR - Ad hoc: MorphoSys' Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction

Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014 MANIFEST-2 met primary endpoint, nearly doubling SVR35 response rate (66% versus 35%) The key secondary endpoints assessing symptom reduction, TSS50 and absolute change in TSS, showe...

MOR - MorphoSys' Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction

MANIFEST-2 met primary endpoint, nearly doubling SVR35 response rate (66% versus 35%) The key secondary endpoints assessing symptom reduction, TSS50 and absolute change in TSS, showed significant improvements for intermediate-risk patients (p<0.05, p<0.02, respectively) and strong n...

MOR - MorphoSys: Buying Constellation Was A Desperate Measure

2023-11-20 13:26:45 ET Summary MorphoSys AG has faced disappointments with some of its programs not performing well in trials and in the market. The company's recent acquisition of Constellation Pharma is seen as a desperate measure by analysts. The upcoming release of topline...
Previous 10 Next 10